GlassScriptPhysician profile
Florence Cabot
NPI 1477805273
$14,278.38
in general payments reported to CMS, 2019-2025
22 companies · $2,598 in 2025
The $2,598 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,018 · 2020: $2,170 · 2021: $1,898 · 2022: $1,667 · 2023: $1,876 · 2024: $1,050 · 2025: $2,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,524.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $6,120.54 | 2019-2024 | Veritas Vision System, Tecnis Iol |
| Alcon Vision LLC | $3,039.58 | 2019-2025 | Clareon, Centurion, Unity |
| Bausch & Lomb Americas INC. | $2,069.20 | 2022-2025 | Stellaris, Envista Mx60 Iol, Ic-8 Apthera Iol |
| Nova Eye, INC. | $789.72 | 2025 | |
| Dompe US, INC. | $453.25 | 2021-2022 | |
| Harrow Eye, LLC | $324.16 | 2025 | Vevye |
| Mallinckrodt Hospital Products INC. | $272.35 | 2022-2025 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $247.17 | 2021 | |
| Novartis Pharmaceuticals Corporation | $238.56 | 2019 | |
| Oyster Point Pharma, INC. | $172.90 | 2023 | Tyrvaya |
| Shire North American Group INC | $122.29 | 2019 | |
| Quidel Corporation | $93.39 | 2019 | |
| Biotissue Holdings INC. | $70.85 | 2022-2024 | |
| Tarsus Pharmaceuticals, INC. | $65.80 | 2025 | Xdemvy |
| Staar Surgical Company | $39.00 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $36.11 | 2023 | |
| Beaver-Visitec International, INC. | $31.45 | 2019 | |
| Carl Zeiss Meditec Cataract Technology INC. | $28.57 | 2024 | |
| Baudax Bio INC. | $18.37 | 2021 | |
| Rayner Intraocular Lenses Limited | $17.33 | 2023 | Omidria, Rayone Spheric, Rayone Emv |
| Sun Pharmaceutical Industries INC. | $16.71 | 2019 | |
| Glaukos Corporation | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florence Cabot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.